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Abstract 
Purpose 
The purpose of this study was to investigate the cardiovascular hemodynamic effects of Red 
Bull® Energy Drink during prolonged, simulated, monotonous driving. 
Methods 
This was a double-blind, within-subjects-design, crossover study. Twelve healthy volunteers 
(21.7 ± 0.8 years old) experienced each of three conditions at various times: 1) consumption 
of Red Bull® Energy Drink; 2) consumption of placebo-controlled drink; and 3) no test 
drink. All subjects undertook 90-min periods of simulated monotonous driving, during which 
physiological measurements were made. The variables recorded were cardiovascular indices, 
i.e., mean blood pressure (MBP), cardiac output (CO), electrocardiogram RR interval (RR), 
total peripheral-vascular resistance (TPR: = MBP/CO), and normalized pulse volume (NPV). 
Additional parameters were the standard deviation of lateral position, i.e., the weaving of the 
car, and subjective rating of sleepiness. 
Results 
CO, RR, and TPR during the monotonous task were significantly different in those 
consuming the energy drink as compared with those receiving the placebo and as compared 
with no drink values. The energy drink elicited a cardiac-dominant reaction pattern, while the 
other conditions demonstrated the vascular-dominant reaction pattern typically observed in 
monotonous driving tasks. The observed differences indicate the cardiovascular system being 
more aroused with the energy drink. 
Conclusion 
The effects of Red Bull® Energy Drink were reflected in cardiovascular hemodynamic 
phenomena especially to the heart function, and we conclude that consumption of this drink 
before long-distance driving in non-sleepy drivers could facilitate more physiologically 
active, and possibly safer, driving. 
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Introduction 
Driving while drowsy is a major cause of serious traffic accidents in industrial nations (Philip 
et al. 2001). Causes of driver sleepiness include sleep restriction, sleep disorders, circadian 
factors, and driving-related factors such as monotonous driving and low traffic density. A 
motorway is a prime example of a monotonous driving environment, and some studies 
estimate that sleepiness accounts for about 20% of all motor vehicle accidents on such roads 
(Maycock 1996; Horne and Reyner 1995). 
To prevent sleep-related traffic accidents on motorways, public campaigns recommend 
scheduled breaks, preferably involving a nap, between driving sessions. Although such 
breaks are the most effective means of reducing traffic accidents (Reyner et al. 2010), drivers 
usually take other countermeasures against sleepiness during or before driving, in particular 
using strategies such as opening the window and listening to music while driving. However, a 
recent study reported that these strategies cannot be recommended as sole countermeasures 
against driver sleepiness (Schwarz et al. 2012). As a commonly used alternative, 
consumption of caffeinated beverages, e.g., coffee, tea, colas, and energy drinks, could be 
useful. This countermeasure has been proven effective, particularly when driving in the early 
morning, at night, or when sleep restricted (Biggs et al. 2007; Philip et al. 2006; Reyner and 
Horne 2000, 1997). 
Energy drinks have recently become popular worldwide. From a global perspective, one of 
the most popular energy drinks appears to be Red Bull® Energy Drink (RBED). The RBED 
sold in Japan contains several ingredients including caffeine, arginine, B vitamins, and 
inositol, a combination that differs slightly from that in the original version used in all other 
studies to date. The original version has been demonstrated to produce positive effects on 
cognitive performance, fatigue, attention, and driving performance in prolonged driving 
(Mets et al. 2011; Gershon et al. 2009; Reyner and Horne 2002; Horne and Reyner 2001) and 
extended endurance and improved exercise performance (Ivy et al. 2009), in the absence of 
ergogenic benefit for women athletes engaging in sprint-based exercise (Astorino et al. 2012). 
In addition, in laboratory tests of mental performance, RBED improved reaction time, 
subjective alertness, concentration, and memory (Warburton et al. 2001; Alford et al. 2001). 
In terms of the positive effects on driving performance, validation tests were based on the 
measurement of performance indices, e.g., the number of lateral lane crossings, standard 
deviation of lateral position (i.e., weaving of the car), and reaction time; questionnaires on 
subjective sleepiness; and physiological indicators of sleepiness (electroencephalography) 
and fatigue (heart rate variability). This information has been derived from driving simulator 
studies (Mets et al. 2011; Gershon et al. 2009; Reyner and Horne 2002; Horne and Reyner 
2001). 
However, despite such findings, further studies are necessary to validate the positive effects 
of RBED. In particular, to the best of our knowledge, there are no published studies 
concerning the detailed cardiovascular hemodynamic effects of RBED during prolonged 
motorway driving. Such studies are desirable because cardiovascular reactivity is known for 
reflecting arousal (Lang et al. 1997). In the present study we therefore focused on 
hemodynamic reactivity, assessed during an experiment using a driving simulator. An 
experimental paradigm was developed in which 500 ml of placebo-controlled drink or the 
same volume of RBED mixed with orange juice was consumed, followed by 90 min of 
monotonous driving. In a third condition, the same subjects drove for 90 min without having 
consumed any test beverage. Based on the previous research discussed above, we 
hypothesized that, compared with placebo-control or no drink, RBED would have a 
significant effect on cardiovascular variables. 
Subjects and methods 
This study was a double-blind, placebo-controlled, crossover trial with a three-stage, within-
subjects design. The study safeguards and protocols were approved by the ethics commission 
of the Faculty of Medicine of Kanazawa University on June 2011 (No. 201), and the study 
was performed in accordance with the ethical standards laid down in the 1964 Declaration of 
Helsinki and its later amendments. All subjects agreed to take part in the study voluntarily 
and signed an informed consent statement before participating. 
Subjects 
Twelve healthy adult men, with a mean age of 21.7 ± 0.8 years and body weight of 63.2 ± 4.1 
kg participated in the study. Subjects were regular drivers (more than 5,000 km/year), had 
been in the possession of a driver license for at least one year, were non-smokers, and had 
regular sleeping hours. The Japanese version of the Epworth Sleepiness Scale (JESS) was 
administered to assess general levels of daytime sleepiness (Takegami et al. 2009). Subjects 
with JESS scores exceeding 10 were excluded from participation (Mets et al. 2011). Other 
inclusion criteria were moderate caffeine consumption (one to three glasses of caffeine-
containing beverages per day) and infrequent energy drink consumption (less than one drink 
per month). Subjects abstained from alcohol consumption from 24 h before the start of the 
test day. 
Experimental design 
The study was comprised of one training day and three test days for each subject. On the 
training day, participants were screened and familiarized with the test procedures using a 
driving simulator, which is described below. Participants were assigned at random to a 
protocol in which each of the following conditions including a 2- or 3-day reversal period 
were applied in the order shown in Table 1: (1) consumption of RBED (RB), (2) consumption 
of placebo-control drink (Cont), and (3) no test drink consumed (no drink; ND). The order of 
the conditions was balanced across subjects. 
Table 1 Summary of the study design 
Group Number of Subjects 1st Stage Reversal period 2nd stage Reversal period 3rd stage 
A 2 ND 
2 or 3 days 
Cont 
2 or 3 days 
RB 
B 2 ND RB Cont 
C 2 Cont ND RB 
D 2 Cont RB ND 
E 2 RB ND Cont 
F 2 RB Cont ND 
Note: The study was a double-blind, placebo-controlled, 2 × 6 crossover trial with a three-
stage, within-subjects design. 
Note: ND = no test drink administered, Cont = placebo-controlled drink, RB = Red Bull® 
Energy Drink. 
On each of the test days, after checking all abovementioned criteria, the four stages of the 
experiment were performed in the following order with subjects sitting in a quiet, 
temperature-controlled, driving simulator: (a) sensors were attached in the appropriate 
positions, which took at least 15 min; (b) a rest period of 10 min; (c) the drink was consumed 
over a period of 5 min; and (d) a simulated monotonous driving period of 90 min. Each test 
was performed over a 120-min period. In order to simulate a real monotonous driving 
situation, each subject was previously informed that they had to continue driving safely, as 
though they were actually driving, that they should maintain a speed of 80~120 km/h, and 
that they should drive within a specified lane. Test sessions were performed either in the 
morning (10:00-12:00 AM) or in the afternoon (13:00-15:00 PM) in a balanced manner. Each 
subject started each test day at the same time. In addition, for each of the test sessions, 
subjects were allowed to have a meal 2 h prior to the experiment so that the food was not 
likely to affect the subject’s sleepiness. 
Test drinks 
The test drinks were: 1) 250 ml of RBED mixed with 250 ml orange juice (Tropicana 100% 
Fruit Orange, Kirin Beverage Company Ltd., Tokyo) or 2) 250 ml orange juice mixed with 
250 ml sparkling water (placebo-control drink), administered before driving. Each 250-ml 
RBED (Red Bull® Energy Drink 250 ml, Red Bull Japan Ltd., Tokyo, Japan) contains 10.7 g 
carbohydrate, 80 mg caffeine, 120 mg arginine (amino acids), 80 mg sodium, and 7 mg 
inositol and vitamins (niacin, pantothenic acid, vitamin B6, vitamin B2, and vitamin B12). It 
should be noted that taurine is not included in the Japanese drink. The placebo-control drink 
was adjusted using Warburton’s method (Warburton et al. 2001) to ensure it had a similar 
taste and color to the RBED mixed with orange juice. Drinks were consumed within 5 min 
before driving. After the study was completed and data were analyzed, the treatment code 
was revealed by a person at Kanazawa University who had not participated in the rest of the 
study. 
Measurement quantities and apparatus 
Driving tests were performed using a driving simulator, which had previously been 
constructed at Kanazawa University and validated in terms of usefulness as a simulator 
(Yamakoshi et al. 2009b; Yamakoshi et al. 2009a). The simulator consists of an adjustable 
car seat, steering wheel, gear lever, clutch, brake, and accelerator pedals for vehicle control. 
The system generates realistic monotonous roadway scenery, which is projected on a 1219 × 
1626-mm screen, placed 1.3 m in front of the midpoint between the driver’s eyes. The screen 
provided the driver with a 65° horizontal field of view. Auditory feedback is provided by 
speakers and includes engine sound. In addition, the road condition is transmitted through the 
steering wheel by mechanical vibration. 
We measured the following cardiovascular variables during the experiment: systolic, mean, 
and diastolic blood pressure (SBP, MBP, and DBP, respectively) in the proximal phalanx of 
the left index finger; cardiac output (CO), determined using admittance cardiography 
triggered by the electrocardiogram RR interval (RR); total peripheral vascular resistance 
(TPR = MBP/CO); and normalized pulse volume (NPV) as an indication of local peripheral 
vascular resistance. These variables were all acquired in a beat-by-beat manner. The BP and 
CO monitoring systems were developed as experimental instruments and have been described 
fully elsewhere (Yamakoshi 2004; Yamakoshi et al. 1980; Ito et al. 1976) The BP system, 
utilizing the volume-compensation principle (Yamakoshi et al. 1980), is capable of 
measuring instantaneous BP in the finger, and the admittance cardiograph (Ito et al. 1976) 
provides an instantaneous indication of CO. The finger photo-plethysmograph (MPN1001, 
Medisens Co. Ltd., Tokyo, Japan) consists of a near-infrared light source and a photosensor, 
which were placed on opposite sides of the distal part of the basal phalanx of the left middle 
finger. NPV was obtained from the DC and AC (pulsatile) components of the finger photo-
plethysmograph signal. This measure has been proposed as a valid index of α-adrenergic 
sympathetic activity in the finger arteriolar vessels (Matsumura and Yamakoshi 2013; Lee et 
al. 2013; Sawada et al. 2001). A logarithmic transformation was applied to the NPV values (= 
lnNPV) to normalize the distribution. 
Driving performance was measured by a single-axis accelerometer (FAS-A, Microstrain Inc., 
Williston, VT, USA) attached to the center of the steering wheel: we adopted the standard 
deviation of the steering-wheel reversal rate (SRR) (Oron-Gilad et al. 2008) as an index of 
driving performance. 
In this experiment the level of sleepiness, as estimated from verbal answers to a questionnaire 
read to subjects by an investigator at 10-min intervals during the driving task, was also 
measured. Subjects reported their perceived sleepiness on a 9-level scale from Level-1 (very 
alert) to Level-9 (very sleepy, an effort to stay awake, fighting sleep); this is referred to as the 
Japanese version of the Karolinska Sleepiness Scale (KSS-J) (Kaida et al. 2006). 
Data analysis 
The data for each condition (RB, Cont, and ND) and period (0–30, 30–60, and 60–90 min) 
were compared statistically by means of two-way repeated-measures analysis of variance 
(ANOVAs). The Greenhouse-Geisser correction was applied to the degree of freedom where 
appropriate. Bonferroni tests for post-hoc comparison were used with a significance level of 
5%. To exclude individual differences in absolute value, the delta change (∆) in reactivity 
was calculated by subtracting averaged rest period (5-min) values from each value, and then 
these values were averaged over 30 min. Statistical analyses were performed using IBM 
SPSS Statistics 21 for Windows (IBM Inc., Tokyo, Japan). 
Results 
Summarized results of condition (RB, Cont, and ND) in each of the three periods (0–30, 30–
60, and 60–90 min) in terms of cardiovascular variables and SRR, and KSS-J are shown in 
Figure 1 and Figure 2, respectively. The results of a series of separate ANOVAs are 
summarized in Table 2. 
Figure 1 Summarized results of the effects of condition (RBED, placebo-control, and no 
drink) and period (0–30, 30–60, and 60–90 min) on cardiovascular variables and SRR. 
Note: RBED = Red Bull® Energy Drink; SD = standard deviation; SEM= standard error of 
the mean; MBP = mean blood pressure; CO = cardiac output; RR = electrocardiogram RR 
interval; TPR = total peripheral-vascular resistance; lnNPV = ln-normalized pulse volume; 
SRR = standard deviation of the steering-wheel reversal rate. 
Figure 2 Summarized results of the effects of condition (RBED, placebo-control, and no 
drink) and period (0–30, 30–60 and 60–90 min) on KSS-J. Note: KSS-J = Japanese version 
of the Karolinska Sleepiness Scale. 
Table 2 Summary of results of two-way repeated-measure analysis of variance 
Measures 
Main effect  Interaction 
Condition Period Condition × Period 
F2, 22 p ηP2 F2, 22 p ηP2 F4, 44 p ηP2 
Hemodynamics           
 MBP 0.08 n.s. .007 27.2 <.001 .712 0.83 n.s. .070 
Cardiac           
 CO 3.19 n.s. .225 13.8 <.001 .557 2.70 <.05 .197 
 RR 0.49 n.s. .043 11.6 <.001 .513 7.22 <.001 .396 
Vascular           
 TPR 0.95 n.s. .079 12.1 <.001 .524 3.13 <.05 .221 
 lnNPV 2.81 n.s. .203 2.10 n.s. .160 7.76 <.001 .414 
Performance           
 SRR 0.19 n.s. .017 12.3 <.001 .528 0.84 <.01 .259 
  F10, 100 p ηP2 F10, 110 p ηP2 F20, 220 p ηP2 
Subjective           
 KSS-J 2.42 n.s. .180 54.9 <.001 .833 1.24 n.s. .102 
Note: MBP = mean blood pressure, CO = cardiac output, RR = electrocardiogram RR 
interval, TPR = total peripheral resistance, lnNPV = ln-normalized pulse volume, SRR = 
standard deviation of the steering-wheel reversal rate, KSS-J = Japanese version of the 
Karolinska Sleepiness Scale. 
Each condition n = 12. 
Mean blood pressure: MBP 
We observed a significant main effect of period: MBP gradually increased over time for all 
conditions. 
Cardiac output: CO 
The interaction between condition and period was significant. There was a significant main 
effect of period: CO gradually increased over time in RB and Cont. Among the conditions, 
post-hoc tests were significant for RB vs. ND (p < .05) and RB vs. Cont (p < .05) for the last 
60–90 period; RBED increased CO significantly more than the other two conditions. 
Electrocardiogram RR interval: RR 
The interaction between condition and period was significant. There was a significant main 
effect of period: RR gradually decreased over time in RB and Cont. Among the conditions, 
post-hoc tests showed RBED tended to reduce the RR for the last 60–90 min period, but this 
was not significant (RB vs. ND, p = .088). 
Total peripheral vascular resistance: TPR 
We observed a significant main effect of period: TPR gradually increased over time in ND 
and Cont. Among the conditions, post-hoc tests showed that TPR tended to be smaller for 
RBED than for placebo-control drink or no drink for the last 60–90 period, but this trend did 
not reach significance (RB vs. ND, p = .117; RB vs. Cont, p = .215). Unlike ND and Cont, 
RBED did not affect TPR. 
Normalized pulse volume: NPV 
The interaction between condition and period was significant. Among the conditions, post-
hoc tests were significant for RB vs. ND (p < .01) and Cont vs. ND (p < .05) for the first 0–30 
min period; RBED and placebo-control drink reduced the NPV (i.e., caused vasoconstriction) 
in the first period. 
Standard deviation of the steering-wheel reversal rate: SRR 
The interaction between condition and period was significant. There was a significant main 
effect of period: SRR gradually increased in Cont. 
Japanese version of the Karolinska Sleepiness Scale: KSS-J 
We observed a significant main effect for period: KSS-J gradually increased over time with 
all conditions. 
Discussion 
In previous studies, the effects of Red Bull® Energy Drink, RBED, were assessed in terms of 
subjective driving quality and driving performance (Mets et al. 2011; Gershon et al. 2009; 
Reyner and Horne 2002; Horne and Reyner 2001). The purpose of the study reported here 
was to expand the data available on RBED by examining its hemodynamic effects during 
long-distance driving. To this end, we conducted a laboratory experiment using simulated 
monotonous driving, and recorded hemodynamic variables under double-blind counter-
balanced crossover experimental conditions. As expected, the findings clearly indicated that 
RBED significantly changed cardiovascular variables in the direction of arousal, i.e., 
elevation in cardiac function, as compared with the placebo-control or no drink. These results 
suggest that RBED has positive effects on those undertaking prolonged driving in that their 
cardiovascular system is in a more responsive state and this in turn may improve safety in this 
situation. 
BP is generally known as the final output of the cardiovascular system through the circulatory 
regulation system. That is, according to the simplified circulatory regulation model (deBoer 
et al. 1987), BP is fed back by the heart and/or the peripheral vessels through the autonomic 
nervous system so as to maintain the BP at a desired level (see Figure 3). In this model, the 
heart modifies CO (and RR) and the peripheral vessels modify TPR (and NPV). The 
controlled BP is therefore calculated as “BP = CO × TPR”. As described above, if BP is 
elevated, the mechanism responsible could be described as having two patterns: one is via an 
increase in cardiac function (the cardiac-dominant reaction pattern: the rise in BP is mainly 
due to increased CO and decreased RR), the other is via an increase in vascular function (the 
vascular-dominant reaction pattern: the rise in BP is mainly due to increased TPR and 
diminished NPV). Typically, the former is observed in active coping (coping exerted under 
the presence of response-reinforcement contingency: it enables individuals to work on the 
stressful task in a successful manner), the latter in passive coping (coping exerted under the 
absence of response-reinforcement contingency: it forces individuals to tolerate only 
passively) (Sawada et al. 2002; Williams 1986; Obrist 1981). In the present study, MBP 
increased in all groups with time. However, the underlying mechanism of MBP elevation 
appeared to differ in each group. First, RBED demonstrated the cardiac-dominant reaction 
pattern, due to the rise in CO and decrease in RR (see Figure 3, Pattern 1). Second, the two 
control conditions (Cont and ND) exhibited the vascular-dominant reaction pattern, due to the 
rise in TPR and decrease in NPV (see Figure 3, Pattern 2), which means that vasoconstriction 
occurred. In fact, this passive coping is a distinctive response in monotonous driving 
situations (Yamakoshi et al. 2009b; Yamakoshi et al. 2009a; Yamakoshi et al. 2006), and a 
reaction typical to this pattern was observed in the two control conditions as mentioned 
above. Interestingly, however, despite the monotonous driving task, RBED triggered a 
change to the opposite (active coping: cardiac-dominant) pattern. This might be in part 
because the 80 mg (approximately 1.3 mg/kg in this study) of caffeine in RBED had a 
pharmacological effect on the body (specifically the heart). 
Figure 3 Schematic drawing of the simplified circulatory regulation model. Note: BP = 
blood pressure; CO = cardiac output; RR = electrocardiogram RR interval; TPR = total 
peripheral vascular resistance; NPV = normalized pulse volume. 
In fact, the effects of caffeine alone on cardiovascular indices have been reported in many 
previous studies (Green and Suls 1996; Lovallo et al. 1991; MacDougall et al. 1988; France 
and Ditto 1988; Lane and Williams 1985; Whitsett et al. 1984; Lane 1983). First, it has been 
reported that caffeine and psychological stress have similar effects on cardiovascular 
reactivity (Lane 1983). In this study 200–250 mg of caffeine consumption was found to 
elevate BP and decrease RR in healthy young males and females during periods of rest and 
stress (MacDougall et al. 1988; Lane and Williams 1985; Lane 1983). Most notably, (Lovallo 
et al. 1991) examined the cardiovascular hemodynamic effects of 3.3 mg/kg caffeine plus 
behavioral stress in men at either low or high risk of essential hypertension. During the task 
there was found to be a supra-additive increase in the SBP response, which resulted from an 
enhanced rise in CO together with a decrease in RR, producing equivalent BP increases in 
both groups. Such physiological reactions are plausible as already described above using a 
circulatory regulation model, and our RBED findings are consistent with this result. Thus, it 
could be hypothesized that 80 mg caffeine in RBED, although less than half the amount of 
caffeine used in these previous studies, could be the main active ingredient with regard to 
cardiovascular behavior during prolonged, simulated, monotonous driving. However, the 
other ingredients of RBED, for example taurine, may have contributory effects on such 
reactions, as some authors have speculated (Reyner and Horne 2002; Horne and Reyner 
2001; Alford et al. 2001), so this will need to be investigated, for example by including 80 
mg caffeine control arms in further studies. Despite all of these considerations it is still worth 
bearing in mind that both RBED in combination with prolonged monotonous driving and the 
independent task itself produce an elevation in BP, which may have implications for long-
distance drivers. 
Subjective sleepiness, as assessed by KSS-J, showed a non-significant tendency to be higher 
in the two control conditions as compared with RBED (see Figure 2). This is at odds with 
previous research on RBED (Mets et al. 2011; Gershon et al. 2009; Reyner and Horne 2002; 
Horne and Reyner 2001). Meanwhile, the standard deviation of SRR as an index of driver 
performance showed the effectiveness of RBED relative to the two control conditions, which 
did not differ significantly from each other in this study. This also contradicts the findings of 
previous studies (Mets et al. 2011; Gershon et al. 2009; Reyner and Horne 2002; Horne and 
Reyner 2001). We can think of two reasons for this discrepancy. One is the relatively short 
driving time in this study. We used a 90-min monotonous driving task, while such tasks in 
other studies exceeded 120 min. The other is the difference in experimental design and 
purpose. In previous studies, RBED was given to sleepy subjects, i.e., sleepiness was 
enhanced by previously undertaking a long driving task (Mets et al. 2011) or by restricting 
sleep to 5 h the night before (Reyner and Horne 2002; Horne and Reyner 2001). It could 
therefore be said that subjective sleepiness was extremely high and driving performance 
accordingly poor in these previous studies. Taking this into consideration, it could be 
hypothesized that RBED changes hemodynamic behavior relatively rapidly in the positive 
direction in sleepy drivers, or that the cardiac-dominant physiological response indicated in 
this study will have positive effects on subsequent performance. Further studies should be 
conducted to validate these hypotheses. In contrast to monotonous driving, it is of great 
interest to consider whether or not RBED could enhance driving performance and 
physiological behavior in scenarios such as motor racing. Racing drivers face extreme levels 
of physical and mental stress (Matsumura et al. 2011; Yamakoshi et al. 2010), which RBED 
could potentially alleviate, thereby helping drivers maintain better concentration. Further 
investigations of this scenario will therefore be needed in a driving simulator and in real 
racing conditions. 
One of the limitations of this study was that this test was conducted in a driving simulator 
environment. The development of sleepiness and the experience of monotony may differ 
between simulated and actual driving. The absence of actual risk in the driving simulator also 
differs from on-the-road driving. The effect of RBED on driving performance should 
therefore preferably be replicated in real situations. Secondly, with a mean age of 21.7, the 
population of only male drivers was relatively young. Although energy drinks are popular 
among this age group, it might be interesting to examine the effects of RBED in older, more 
experienced drivers. Thirdly, we used the same volume of test drinks in this study. However 
the possible effects of body weight to RBED volume ratio are likely to be significant and this 
needs to be explored fully in future studies. Finally, our experimental paradigm of simulated 
monotonous driving was relatively short. More detailed research into the relationship 
between cardiovascular hemodynamics and driving performance in long-distance driving 
should be conducted in the future. 
Conclusions 
Red Bull® Energy Drink, RBED, significantly changed cardiovascular system behavior into 
the cardiac-dominant reaction pattern, whereas the placebo-control and ‘no drink’ subjects 
exhibited the expected distinctive vascular-dominant reaction pattern, in monotonous driving 
situations. These results suggest that RBED consumption by non-sleepy drivers before 
prolonged driving could help to increase arousal, leading to a safer driving status by 
improving concentration. 
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